The source of the PB1 gene in influenza vaccine reassortants selectively alters the hemagglutinin content of the resulting seed virus

Journal of Virology

Volumn 87, Issue 10, 2013, Pages 5577-5585

  Cobbin, Joanna C A ^a   Verity, Erin E ^b   Gilbertson, Brad P ^a   Rockman, Steven P ^b   Brown, Lorena E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CSL LIMITED   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; MEMBRANE ANTIGEN; MESSENGER RNA; VIRUS NUCLEOPROTEIN; VIRUS RNA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DOG; EMBRYO; GENE FUNCTION; GENE IDENTIFICATION; GENETIC REASSORTMENT; GENOTYPE; GROWTH RATE; INFLUENZA VIRUS; NONHUMAN; PB1 GENE; PRIORITY JOURNAL; PROTEIN CONTENT; RETROSPECTIVE STUDY; SEASONAL INFLUENZA; VIRION; VIROGENESIS; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS STRAIN;

ANIMALS; HEMAGGLUTININS; HUMANS; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE; REASSORTANT VIRUSES; TECHNOLOGY, PHARMACEUTICAL; VIRAL PROTEINS;

EID: 84877356535     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02856-12     Document Type: Article

References (39)

1. World Health Organization. 2009. Influenza (seasonal). Fact sheet no. 211. http://www.who.int/mediacentre/factsheets/fs211/en/index.html.
2. Nordin J, Mullooly J, Poblete S, Strikas R, Petrucci R, Wei F, Rush B, Safirstein B, Wheeler D, Nichol KL. 2001. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J. Infect. Dis. 184:665-670.
3. Couch RB, Kasel JA. 1983. Immunity to influenza in man. Annu. Rev. Microbiol. 37:529-549.
4. Wiley D, Wilson I, Skehel J. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373.
5. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. 1982. The antigenic structure of the influenza-virus A/PR/8/34 hemagglutinin (H-1 subtype). Cell 31:417-427.
6. Webster RG, Laver WG, Air GM, Schild GC. 1982. Molecular mechanisms of variation in influenza viruses. Nature 296:115-121.
7. Laver WG, Air GM, Webster RG, Markoff LJ. 1982. Amino acid sequence changes in antigenic variants of type A influenza virus N2 neuraminidase. Virology 122:450-460.
8. Kilbourne ED, Murphy JS. 1960. Genetic studies of influenza viruses. I. Viral morphology and growth capacity as exchangeable genetic traits. Rapid in ovo adaptation of early passage Asian strain isolates by combination with PR8. J. Exp. Med. 111:387-406.
9. Kilbourne ED. 1969. Future influenza vaccines and the use of genetic recombinants. Bull. World Health Org. 41:643-645.
10. Kilbourne ED, Schulman JL, Schild GC, Schloer G, Swanson J, Bucher D. 1971. Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine. J. Infect. Dis. 124:449-462.
11. Bergeron C, Valette M, Lina B, Ottmann M. 2010. Genetic content of influenza H3N2 vaccine seeds. PLoS Curr. 2:RRN1165. doi:10.1371/currents.RRN1165.
12. Fulvini AA, Ramanunninair M, Le J, Pokorny BA, Arroyo JM, Silverman J, Devis R, Bucher D. 2011. Gene constellation of influenza A virus reassortants with high growth phenotype prepared as seed candidates for vaccine production. PLoS One 6:e20823. doi:10.1371/journal.pone.0020823.
13. Oxford JS, Corcoran T, Newman R, Major D, Schild GC. 1986. Biochemical and antigenic analysis using monoclonal antibodies of a series of influenza A (H3N2) and (H1N1) virus reassortants. Vaccine 4:9-14.
14. Baez M, Palese P, Kilbourne ED. 1980. Gene composition of highyielding influenza vaccine strains obtained by recombination. J. Infect. Dis. 141:362-365.
15. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U. S. A. 97:6108-6113.
16. Groth FdS, Webster RG. 1966. Disquisitions of original antigenic sin. I. Evidence in man. J. Exp. Med. 124:331-345.
17. Tannock GA, Paul JA, Barry RD. 1984. Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect. Immun. 43:457-462.
18. Wei Z, McEvoy M, Razinkov V, Polozova A, Li E, Casas-Finet J, Tous GI, Balu P, Pan AA, Mehta H, Schenerman MA. 2007. Biophysical characterization of influenza virus subpopulations using field flow fractionation and multiangle light scattering: correlation of particle counts, size distribution and infectivity. J. Virol. Methods 144:122-132.
19. van Elden LJ, Nijhuis M, Schipper P, Schuurman R, van Loon AM. 2001. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J. Clin. Microbiol. 39:196-200.
20. Cavrois M, De Noronha C, Greene WC. 2002. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 20:1151-1154.
21. Brown LE, Murray JM, White DO, Jackson DC. 1990. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin. Arch. Virol. 114:1-26.
22. Florent G. 1980. Gene constellation of live influenza A vaccines. Arch. Virol. 64:171-173.
23. Xu X, Kilbourne ED, Hall HE, Cox NJ. 1994. Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses. J. Infect. Dis. 170:1432-1438.
24. Yángüez E, Nieto A. 2011. So similar, yet so different: selective translation of capped and polyadenylated viral mRNAs in the influenza virus infected cell. Virus Res. 156:1-12.
25. Yángüez E, Rodriguez P, Goodfellow I, Nieto A. 2012. Influenza virus polymerase confers independence of the cellular cap-binding factor eIF4E for viral mRNA translation. Virology 422:297-307.
26. González S, Ortín J. 1999. Distinct regions of influenza virus PB1 polymerase subunit recognize vRNA and cRNA templates. EMBO J. 18:3767-3775.
27. Li C, Hatta M, Nidom CA, Muramoto Y, Watanabe S, Neumann G, Kawaoka Y. 2010. Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence. Proc. Natl. Acad. Sci. U. S. A. 107:4687-4692.
28. Murakami S, Horimoto T, Mai LQ, Nidom CA, Chen H, Muramoto Y, Yamada S, Iwasa A, Iwatsuki-Horimoto K, Shimojima M, Iwata A, Kawaoka Y. 2008. Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells. J. Virol. 82:10502-10509.
29. Marjuki H, Yen Franks H-LJ, Webster RG, Pleschka S, Hoffmann E. 2007. Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascade. Virol. J. 4:134.
30. Li C, Hatta M, Watanabe S, Neumann G, Kawaoka Y. 2008. Compatibility among polymerase subunit proteins is a restricting factor in reassortment between equine H7N7 and human H3N2 influenza viruses. J. Virol. 82:11880-11888.
31. Abt M, de Jonge J, Laue M, Wolff T. 2011. Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content. Vaccine 29: 5153-5162.
32. Moulés V, Terrier O, Yver M, Riteau B, Moriscot C, Ferraris O, Julien T, Giudice E, Rolland Erny J-PA, Bouscambert-Duchamp M, Frobert E, Rosa-Calatrava M, Pu Lin Y, Hay A, Thomas D, Schoehn G, Lina B. 2011. Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particles. Virology 414:51-62.
33. Scheper GC, Proud CG. 2002. Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation? Eur. J. Biochem. 269: 5350-5359.
34. Zuberek J, Jemielity J, Jablonowska A, Stepinski J, Dadlez M, Stolarski R, Darzynkiewicz E. 2004. Influence of electric charge variation at residues 209 and 159 on the interaction of eIF4E with the mRNA 5= terminus. Biochemistry 43:5370-5379.
35. Ling J, Morley SJ, Traugh JA. 2005. Inhibition of cap-dependent translation via phosphorylation of eIF4G by protein kinase Pak2. EMBO J. 24:4094-4105.
36. Ross G, Dyer JR, Castellucci VF, Sossin WS. 2006. Mnk is a negative regulator of cap-dependent translation in Aplysia neurons. J. Neurochem. 97:79-91.
37. Burgui I, Yanguez E, Sonenberg N, Nieto A. 2007. Influenza virus mRNA translation revisited: is the eIF4E cap-binding factor required for viral mRNA translation? J. Virol. 81:12427-12438.
38. Garfinkel MS, Katze MG. 1993. Translational control by influenza virus. Selective translation is mediated by sequences within the viral mRNA 5=-untranslated region. J. Biol. Chem. 268:22223-22226.
39. González S, Ortín J. 1999. Characterization of influenza virus PB1 protein binding to viral RNA: two separate regions of the protein contribute to the interaction domain. J. Virol. 73:631-637.